다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

ABVX

Abivax (ABVX)

Abivax SA

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ABVX

1

일자	시간	출처	헤드라인	심볼	기업
2024/12/24	07:14	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
2024/12/24	06:05	GlobeNewswire Inc.	Abivax Announces a Change to the Composition of its Board of Directors	NASDAQ:ABVX	Abivax SA
2024/11/27	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ABVX	Abivax SA
2024/11/20	06:43	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
2024/11/20	06:30	GlobeNewswire Inc.	Abivax Establishes an At-the-Market (ATM) Program on Nasdaq	NASDAQ:ABVX	Abivax SA
2024/11/20	06:02	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:ABVX	Abivax SA
2024/11/15	06:01	GlobeNewswire Inc.	Abivax presents third quarter 2024 key financial information	NASDAQ:ABVX	Abivax SA
2024/11/15	06:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
2024/11/14	06:01	GlobeNewswire Inc.	Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax	NASDAQ:ABVX	Abivax SA
2024/10/08	05:01	GlobeNewswire Inc.	Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation	NASDAQ:ABVX	Abivax SA
2024/10/04	05:18	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
2024/10/04	05:01	GlobeNewswire Inc.	Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease	NASDAQ:ABVX	Abivax SA
2024/10/03	19:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
2024/10/03	15:31	GlobeNewswire Inc.	Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance	NASDAQ:ABVX	Abivax SA
2024/09/26	19:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
2024/09/26	15:30	GlobeNewswire Inc.	Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024	NASDAQ:ABVX	Abivax SA
2024/09/26	05:30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
2024/09/26	05:01	GlobeNewswire Inc.	Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model	NASDAQ:ABVX	Abivax SA
2024/09/10	05:27	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
2024/09/10	05:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
2024/09/10	05:01	GlobeNewswire Inc.	Abivax presents first-half 2024 financial results	NASDAQ:ABVX	Abivax SA
2024/09/09	19:09	IH Market News	U.S. Futures Rise Amid Inflation Report Anticipation; Oil Prices Climb on Hurricane Threat and Supply Concerns	NASDAQ:ABVX	Abivax SA
2024/08/06	15:30	GlobeNewswire Inc.	Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone	NASDAQ:ABVX	Abivax SA
2024/07/16	05:00	GlobeNewswire Inc.	Abivax Provides Operational and Key Program Update	NASDAQ:ABVX	Abivax SA
2024/06/05	05:26	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
2024/06/05	05:10	GlobeNewswire Inc.	Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting	NASDAQ:ABVX	Abivax SA
2024/05/08	05:26	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA

검색 관련기사 보기:NASDAQ:ABVX

1

JP Morgan Chase

Financial Select Sector

Gold vs US Dollar

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관